Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
260.5 USD | -0.72% | +9.34% | +18.47% |
05-03 | United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing | MT |
05-02 | UBS Adjusts Price Target on United Therapeutics to $300 From $290, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.47% | 11.64B | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Insider Sell: United Therapeutics